Mechanism of Kv2.1 channel inhibition by a selective COX-2 inhibitor SC-791-modification of gating

Brain Research

Volumn 1359, Issue , 2010, Pages 67-74

  Frolov, Roman V ^a,b   Ignatova, Irina I ^a,b   Singh, Satpal ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

COX 2 inhibitor; Potassium channel; SC 791

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; POTASSIUM CHANNEL KV2.1; SC 791; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ARTICLE; CHANNEL GATING; DOSE RESPONSE; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL;

CYCLOOXYGENASE 2 INHIBITORS; HEK293 CELLS; HUMANS; ION CHANNEL GATING; ISOXAZOLES; MEMBRANE POTENTIALS; PATCH-CLAMP TECHNIQUES; SHAB POTASSIUM CHANNELS; SULFONAMIDES;

EID: 77957977131     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.08.062     Document Type: Article

References (34)

1. G. Baranauskas, T. Tkatch, and D.J. Surmeier Delayed rectifier currents in rat globus pallidus neurons are attributable to Kv2.1 and Kv3.1/3.2 K(+) channels J. Neurosci. 19 1999 6394 6404
2. E.A. Blomme, K.S. Chinn, M.M. Hardy, J.J. Casler, S.H. Kim, A.C. Opsahl, W.A. Hall, D. Trajkovic, K.N. Khan, and C.S. Tripp Selective cyclooxygenase-2 inhibition does not affect the healing of cutaneous full-thickness incisional wounds in SKH-1 mice Br. J. Dermatol. 148 2003 211 223
3. R. Bouchard, and D. Fedida Closed- and open-state binding of 4-aminopyridine to the cloned human potassium channel Kv1.5 J. Pharmacol. Exp. Ther. 275 1995 864 876
4. L.I. Brueggemann, A.R. Mackie, B.K. Mani, L.L. Cribbs, and K.L. Byron Differential effects of selective cyclooxygenase-2 inhibitors on vascular smooth muscle ion channels may account for differences in cardiovascular risk profiles Mol. Pharmacol. 76 2009 1053 1061
5. J.M. Dogne, A. Thiry, D. Pratico, B. Masereel, and C.T. Supuran Dual carbonic anhydrase-cyclooxygenase-2 inhibitors Curr. Top. Med. Chem. 7 2007 885 891
6. R.J. Flower The development of COX2 inhibitors Nat. Rev. Drug Discov. 2 2003 179 191
7. R.V. Frolov, I.G. Berim, and S. Singh Inhibition of delayed rectifier potassium channels and induction of arrhythmia: a novel effect of celecoxib and the mechanism underlying it J. Biol. Chem. 283 2008 1518 1524
8. R.V. Frolov, M.M. Slaughter, and S. Singh Effects of celecoxib on ionic currents and spontaneous firing in rat retinal neurons Neuroscience 154 2008 1525 1532
9. R.V. Frolov, V.E. Bondarenko, and S. Singh Mechanisms of Kv2.1 channel inhibition by celecoxib-modification of gating and channel block Br. J. Pharmacol. 159 2010 405 418
10. S.M. Furst, K.N. Khan, W.J. Komocsar, and J. Mennear Screening new drugs for immunotoxic potential: III. Assessment of the effects of selective and nonselective COX-2 inhibitors on T-cell-dependent antibody and natural killer cell responses in the rat J. Immunotoxicol. 2 2005 161 170
11. T. Gonzalez, R. Navarro-Polanco, C. Arias, R. Caballero, I. Moreno, E. Delpon, J. Tamargo, M.M. Tamkun, and C. Valenzuela Assembly with the Kvbeta1.3 subunit modulates drug block of hKv1.5 channels Mol. Pharmacol. 62 2002 1456 1463
12. S. Grosch, T.J. Maier, S. Schiffmann, and G. Geisslinger Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors J. Natl Cancer Inst. 98 2006 736 747
13. M.M. Hardy, E.A. Blomme, A. Lisowski, K.S. Chinn, A. Jones, J.M. Harmon, A. Opsahl, R.L. Ornberg, and C.S. Tripp Selective cyclooxygenase-2 inhibition does not alter keratinocyte wound responses in the mouse epidermis after abrasion J. Pharmacol. Exp. Ther. 304 2003 959 967
14. B.B. Hasinoff, D. Patel, and X. Wu The cytotoxicity of celecoxib towards cardiac myocytes is cyclooxygenase-2 independent Cardiovasc. Toxicol. 7 2007 19 27
15. T. Ishihara, K. Tanaka, S. Tashiro, K. Yoshida, and T. Mizushima Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis Biochem. Pharmacol. 79 2010 1622 1633
16. S.A. Malin, and J.M. Nerbonne Delayed rectifier K + currents, IK, are encoded by Kv2 alpha-subunits and regulate tonic firing in mammalian sympathetic neurons J. Neurosci. 22 2002 10094 10105
17. J.T. Milnes, C.E. Dempsey, J.M. Ridley, O. Crociani, A. Arcangeli, J.C. Hancox, and H.J. Witchel Preferential closed channel blockade of HERG potassium currents by chemically synthesised BeKm-1 scorpion toxin FEBS Lett. 547 2003 20 26
18. H. Misonou, D.P. Mohapatra, E.W. Park, V. Leung, D. Zhen, K. Misonou, A.E. Anderson, and J.S. Trimmer Regulation of ion channel localization and phosphorylation by neuronal activity Nat. Neurosci. 7 2004 711 718
19. H. Murakoshi, and J.S. Trimmer Identification of the Kv2.1 K + channel as a major component of the delayed rectifier K + current in rat hippocampal neurons J. Neurosci. 19 1999 1728 1735
20. K.M. O'Connell, and M.M. Tamkun Targeting of voltage-gated potassium channel isoforms to distinct cell surface microdomains J. Cell Sci. 118 2005 2155 2166
21. B. Ordog, E. Brutyo, L.G. Puskas, J.G. Papp, A. Varro, J. Szabad, and Z. Boldogkoi Gene expression profiling of human cardiac potassium and sodium channels Int. J. Cardiol. 111 2006 386 393
22. S.Y. Park, T.H. Kim, H.I. Kim, Y.K. Shin, C.S. Lee, M. Park, and J.H. Song Celecoxib inhibits Na + currents in rat dorsal root ganglion neurons Brain Res. 1148 2007 53 61
23. A.J. Patel, M. Lazdunski, and E. Honore Kv2.1/Kv9.3, a novel ATP-dependent delayed-rectifier K + channel in oxygen-sensitive pulmonary artery myocytes EMBO J. 16 1997 6615 6625
24. L.H. Pinto, and D.J. Klumpp Localization of potassium channels in the retina Prog. Retin. Eye Res. 17 1998 207 230
25. Y.J. Qu, V.E. Bondarenko, C. Xie, S. Wang, M.S. Awayda, H.C. Strauss, and M.J. Morales W-7 modulates Kv4.3: pore block and Ca2 + -calmodulin inhibition Am. J. Physiol. Heart Circ. Physiol. 292 2007 H2364 H2377
26. A. Scholle, T. Zimmer, R. Koopmann, B. Engeland, O. Pongs, and K. Benndorf Effects of Kv1.2 intracellular regions on activation of Kv2.1 channels Biophys. J. 87 2004 873 882
27. C.S. Tripp, E.A. Blomme, K.S. Chinn, M.M. Hardy, P. LaCelle, and A.P. Pentland Epidermal COX-2 induction following ultraviolet irradiation: suggested mechanism for the role of COX-2 inhibition in photoprotection J. Invest. Dermatol. 121 2003 853 861
28. W. Wang, N. Hino, H. Yamasaki, T. Aoki, and R. Ochi KV2.1 K + channels underlie major voltage-gated K + outward current in H9c2 myoblasts Jpn J. Physiol. 52 2002 507 514
29. C. Wang, H. Li, A. Li, J. Zhang, and R. Xiu Experimental study on the function of cardiomyocytes Clin. Hemorheol. Microcirc. 29 2003 369 374
30. S. Wang, M.J. Morales, Y.J. Qu, G.C. Bett, H.C. Strauss, and R.L. Rasmusson Kv1.4 channel block by quinidine: evidence for a drug-induced allosteric effect J. Physiol. 546 2003 387 401
31. M. Wareing, X. Bai, F. Seghier, C.M. Turner, S.L. Greenwood, P.N. Baker, M.J. Taggart, and G.K. Fyfe Expression and function of potassium channels in the human placental vasculature Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 2006 R437 R446
32. A. Weber, A. Casini, A. Heine, D. Kuhn, C.T. Supuran, A. Scozzafava, and G. Klebe Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition J. Med. Chem. 47 2004 550 557
33. L. Yan, D.J. Figueroa, C.P. Austin, Y. Liu, R.M. Bugianesi, R.S. Slaughter, G.J. Kaczorowski, and M.G. Kohler Expression of voltage-gated potassium channels in human and rhesus pancreatic islets Diabetes 53 2004 597 607
34. Y. Zhang, J. Tao, H. Huang, G. Ding, Y. Cheng, and W. Sun Effects of celecoxib on voltage-gated calcium channel currents in rat pheochromocytoma (PC12) cells Pharmacol. Res. 56 2007 267 274